NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,008 filers reported holding NOVARTIS A G in Q4 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $455,000 | -2.2% | 5,419 | 0.0% | 0.50% | -5.3% |
Q3 2017 | $465,000 | +2.9% | 5,419 | 0.0% | 0.53% | -1.1% |
Q2 2017 | $452,000 | +12.4% | 5,419 | 0.0% | 0.54% | +3.9% |
Q1 2017 | $402,000 | +1.8% | 5,419 | 0.0% | 0.52% | -4.6% |
Q4 2016 | $395,000 | +57.4% | 5,419 | +98.3% | 0.54% | +110.9% |
Q3 2015 | $251,000 | -58.6% | 2,733 | -55.7% | 0.26% | -37.2% |
Q2 2015 | $607,000 | -31.8% | 6,168 | -31.7% | 0.41% | -27.4% |
Q1 2015 | $890,000 | +6.5% | 9,025 | 0.0% | 0.56% | +11.3% |
Q4 2014 | $836,000 | +57.1% | 9,025 | +59.8% | 0.51% | +44.2% |
Q3 2014 | $532,000 | +4.3% | 5,649 | +0.3% | 0.35% | +7.7% |
Q2 2014 | $510,000 | -0.6% | 5,630 | -6.6% | 0.33% | -7.9% |
Q1 2014 | $513,000 | +22.7% | 6,030 | +15.9% | 0.35% | +24.2% |
Q4 2013 | $418,000 | +3.0% | 5,205 | -1.6% | 0.28% | -5.0% |
Q3 2013 | $406,000 | -2.9% | 5,290 | -10.6% | 0.30% | -0.3% |
Q2 2013 | $418,000 | – | 5,915 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |